Profitelligence Profitelligence · Filing Ledger Open TWST research →

Form 8-K · Current Report · Filed 2024-10-15

James Thorburn Transitions to Consulting Role at Twist Bioscience

James Thorburn, previously an employee at Twist Bioscience Corporation, has transitioned into a Strategic Advisor role.

Filer
Twist Bioscience Corporation TWST · NASDAQ
Filed
Accession
0001104659-24-108591
CIK
0001581280
Signal
High impactHealthcare

Details

His employment agreement expired, and he has now entered into a month-to-month consulting agreement with the company at a rate of $25,000 per month, effective October 8, 2024, to complete certain projects.

Items reported

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

Key Executive Departure Contract Extension

Market reaction

Close before filing

$46.64

Next session

-3.4%

Since filing

+233.5%

Latest close

$155.56

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from TWST reporting the same item, with the next session's move:

Twist Bioscience Appoints New CFO Adam Laponis+4.2%

About Twist Bioscience Corporation

Twist Bioscience Corporation is a synthetic biology and biotechnology company that develops and commercializes DNA-based products built on its proprietary silicon-based synthesis platform. Twist Bioscience Corporation’s core offerings include synthetic genes, DNA oligos, oligo pools, library preparation tools, antibody libraries, and other workflow products used in next-generation sequencing, gene editing, drug discovery, diagnostics, and research. The company serves customers across academic, pharmaceutical, biotech, industrial, and agricultural markets, providing scalable tools for applications that require precise, high-quality synthetic DNA. Its platform supports high-throughput manufacturing and a broad product portfolio that helps researchers and developers design, test, and advance biological innovation across multiple life science segments. Headquartered in South San Francisco, California, Twist Bioscience Corporation plays a specialized role in the global market for synthetic DNA and genomics-enabled research tools.

Exchange NASDAQ Industry Diagnostics & Research Company website ↗

Never miss another TWST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts